US drugmaker Pfizer today reported that revenue more than halved during the second quarter of the year as global demand for its Covid-19 vaccines plummeted. Read More
Pfizer’s revenue drops over 50 per cent as Covid-19 vaccine sales wither
Reading Time: < 1 minute